Disialoganglioside GD2 is a promising target for immunotherapy with expression primarily
restricted to neuroectodermal and epithelial tumor cells. Although its role in the maintenance …

Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiological entity
characterized by a typical brain edema. Its pathogenesis is still debated through …

Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiological entity
initially described in 1996. PRES frequently develops in patients with preeclampsia and …

Abstract Purpose of Review To report a series of patients with clinical and radiological
features suggestive of posterior reversible encephalopathy syndrome (PRES) related to …

Background Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic
disorder characterized by seizures, headache, altered mental status, and visual …

Background The neuroimaging manifestations of eclampsia and preeclampsia often
overlap, mainly presenting as posterior reversible encephalopathy syndrome (PRES). The …

The SARS‐CoV‐2 infection affects numerous organs, including the central nervous system.
The neuroinvasive abilities and neuroinflammation may lead to short‐and long‐term …

Introduction The hemolysis-elevated liver enzymes-low platelet counts (HELLP) syndrome
and posterior reversible encephalopathy syndrome (PRES) are rare conditions that can …

En todos los países del mundo, la preeclampsia sigue desempeñando un papel importante
en lo que respecta a la morbilidad y la mortalidad maternofetal. Eclampsia, síndrome …

Interventions: The patient received levetiracetam and edaravone. Outcomes: Her clinical
course was uneventful and she fully recovered without neurological complications Lessons …